The cost‐effectiveness of sacral nerve stimulation (SNS) for the treatment of idiopathic medically refractory overactive bladder (wet) in the UK
ConclusionIn the management of patients with idiopathic OAB wet, the results of this cost‐utility analysis favours SNS (PNE or TLE) over PTNS or OMT, and the most efficient treatment strategy is SNS PNE over BoNT‐A over a 10‐year period.
Source: BJU International - Category: Urology & Nephrology Authors: Silke Walleser Autiero, Natalie Hallas, Christopher D. Betts, Jeremy L. Ockrim Tags: Original Article Source Type: research
More News: Botox | Health | Overactive Bladder | Overactive Bladder Syndrome | UK Health | Urology & Nephrology